[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368019-105":59,"doc-detail-368019-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","anti-fap-car-nk-cells-as-a-novel-targeted-therapy-against-cervical-cancer-and-cancer-associated-fibroblasts","Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts","","The tumor microenvironment (TME) supports an immunosuppressive milieu that drives many cancers, limiting effective immune responses. Chimeric antigen receptor (CAR)-based immunotherapy aims to redirect immune cells to defined antigens to trigger targeted cytotoxicity. Fibroblast activation protein (FAP) is overexpressed across cancers and is promising for CAR approaches. This study tests anti-FAP CAR-NK cells for cervical cancer and cancer-associated fibroblasts, showing enhanced cytotoxicity, degranulation, and elimination in 2D and 3D models, supporting broader applicability in FAP-high diseases.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/anti-fap-car-nk-cells-as-a-novel-targeted-therapy-against-cervical-cancer-and-cancer-associated-fibroblasts/368019/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/anti-fap-car-nk-cells-as-a-novel-targeted-therapy-against-cervical-cancer-and-cancer-associated-fibroblasts/368019.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main therapeutic rationale of anti-FAP CAR-NK cells in this study?","Question",{"text":113,"@type":114},"FAP is overexpressed in cancers and can serve as a target antigen. The study evaluates whether anti-FAP CAR-NK cells redirect NK-mediated killing specifically toward FAP-positive cervical cancer and fibroblasts.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How was FAP expression assessed across cervical cancer models?",{"text":118,"@type":114},"FAP expression was quantified on cervical cancer cell lines, primary cervical cancer tissues, and cells isolated from these tissues, using immunohistochemistry and flow cytometry.",{"name":120,"@type":111,"acceptedAnswer":121},"What evidence supports anti-FAP CAR-NK activity against both tumors and CAFs?",{"text":122,"@type":114},"Anti-FAP CAR-NK cells showed enhanced cytotoxicity and degranulation against FAP-positive targets in 2D co-cultures, and efficiently eliminated cervical cancer cells and cancer-associated fibroblasts in 3D tumor spheroid models.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368019,1790788677,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","ONCOIMMUNOLOGY  \n2025, VOL. 14, NO. 1, 2556714 [https://doi.org/10.1080/2162402X.2025.2556714](https://doi.org/10.1080/2162402X.2025.2556714)  \nAnti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts  \nRobert Poltena, Ivana Kutlea, Jan Lennart Stalpa,b, Jens Hachenberga,b, Ann-Kathrin Seydaa,  \nLavinia Neubert c,d, Jan C. Kampd,e, Constantin von Kaisenbergb, Dirk Schaudien f, Peter Hillemannsb, Rüdiger Klapdora,b,g, Michael Morgana*, and Axel Schambacha,h*  \naInstitute of Experimental Hematology, Hannover Medical School, Hannover, Germany; bDepartment of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany; cInstitute of Pathology, Hannover Medical School, Hannover, Germany; dBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany; e Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany; fDepartment of Pathology and Clinical Chemistry, Fraunhofer Institute for Toxicology and Experimental Medicine, ITEM, Hannover, Germany; gDepartment of Gynecology and Obstetrics, Albertinen Hospital Hamburg, Hamburg, Germany; hDivision of Hematology/ Oncology, Boston Children’s Hospital, Harvard Medical School, Boston, MA, USA  \nABSTRACT  \nThe tumor microenvironment (TME) has a central role in many cancers, particularly by fostering an immunosuppressive milieu. Chimeric antigen receptor (CAR)-based immunotherapy displays a promising strategy to re-direct immune cells toward specific antigens, thereby inducing targeted cytotoxicity. The fibroblast activation protein (FAP) is overexpressed in various cancer types and has shown promise in CAR-based therapies. However, its application in gynecological cancers remains unexplored. This study evaluates the efficacy of anti-FAP CAR-NK cells as a targeted immunotherapy for cervical cancer and cancer-associated fibroblasts (CAFs) . FAP expression was quantified on cervical cancer cell lines, primary cervical cancer tissues, and cells isolated from these tissues. Alpharetroviral SIN vectors were used to transduce NK-92 cells and primary cord blood-derived NK cells with 3rd-generation anti-FAP CARs. Immunohistochemistry and flow cytometry revealed high FAP expression on CaSki cells, cervical cancer tissues, and primary cervical CAFs. In 2D co-cultures with FAP-positive target cells, anti-FAP CAR-NK cells exhibited significantly enhanced cytotoxicity and elevated degranulation compared to control NK cells, with no observed effects against FAP-negative target cells. Primary NK cells revealed high cytotoxicity against cervical cancer cells with a high release of cytolytic enzymes. Anti-FAP CAR-NK cells also showed efficient elimination of cervical cancer cells and CAFs in 3D tumor spheroid models. These findings underscore the potential of anti-FAP CAR-NK cells as a potent therapeutic approach for cervical cancer and suggest broader applicability in diseases characterized by high FAP expression.  \nARTICLE HISTORY  \nReceived 28 March 2025 Revised 22 July 2025 Accepted 31 August 2025  \nKEYWORDS  \nCervical cancer; immunotherapy; adoptive cell therapy; CAR-NK cells; fibroblast activation protein (FAP); chimeric antigen receptor (CAR);  \ncancer-associated fibroblast; tumor microenvironment  \n1. Introduction  \nCervical cancer remains a major global health concern, with an estimated 661,021 new cases and 348,189 deaths reported in 2022, ranking it the fourth-most common cancer in women worldwide. Notably, cervical cancer was reported to be the most frequently diagnosed cancer in 25 countries and the leading cause of cancer-related death in 37 countries, highlighting the burden of this disease.1  \nInvasive, locally advanced cervical cancers are typically treated with chemoradiotherapy with or without immunotherapy. Here, checkpoint inhibitors like Pembrolizumab have become a therapy option for patients with recurrent pla","cbCaia7beISszlig","https://ap.wps.com/l/cbCaia7beISszlig","pdf",4574137,24,"English","# Abstract\n# Introduction\n## Tumor microenvironment and current cervical cancer therapies\n# Key methods and experimental setup\n# Results: FAP expression and CAR-NK cytotoxicity\n# Results: activity in 2D and 3D models\n# Conclusion and therapeutic implications","[{\"question\":\"What is the main therapeutic rationale of anti-FAP CAR-NK cells in this study?\",\"answer\":\"FAP is overexpressed in cancers and can serve as a target antigen. The study evaluates whether anti-FAP CAR-NK cells redirect NK-mediated killing specifically toward FAP-positive cervical cancer and fibroblasts.\"},{\"question\":\"How was FAP expression assessed across cervical cancer models?\",\"answer\":\"FAP expression was quantified on cervical cancer cell lines, primary cervical cancer tissues, and cells isolated from these tissues, using immunohistochemistry and flow cytometry.\"},{\"question\":\"What evidence supports anti-FAP CAR-NK activity against both tumors and CAFs?\",\"answer\":\"Anti-FAP CAR-NK cells showed enhanced cytotoxicity and degranulation against FAP-positive targets in 2D co-cultures, and efficiently eliminated cervical cancer cells and cancer-associated fibroblasts in 3D tumor spheroid models.\"}]","Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts | PDF",1790174387,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/475cc644e75e23862da5898b519a01fd.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8326ec618291abd521c6daadd7b7a618.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b474e21da90086fc22fa59d03f67515b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09c83bc370c769476476dbcdc4cf4d40.webp",980,1306]